Observation of curative effect of triamcinolone acetonide injection combined with antifungal therapy on multiple keloids

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054314

Enrollment

Unknown

Registered

2021-12-13

Start date

2021-12-13

Completion date

Unknown

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple keloids

Interventions

control group:triamcinolone acetonide injection

experimental group 1:triamcinolone acetonide injection+topical Ketoconazole Lotion

experimental group 2:triamcinolone acetonide injection+oral Itraconazole

experimental group 3:triamcinolone acetonide injection+topical salicylic acid

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-60 years who have been diagnosed with multiple keloids; 2. Clinical type: small keloids (d<2cm) and (or) medium-sized keloids (2.0-5.0cm in length, <3.0cm in width); 3. Patients with obvious hyperemia reaction of keloid and rapid infiltration and growth around; 4. Detect fungi 3-4+ under fluorescent staining microscope; 5. Vancouver scale 11-15 points; 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with serious underlying diseases; 2. Those who are breastfeeding or pregnant; 3. Those who are allergic to the research drug; 4. Those with obvious ulceration at the keloid lesions; 5. Those who have taken orally and externally used drugs or skin care products that may affect the test results within 30 days.

Design outcomes

Primary

Measure	Time frame
color;thickness;vascular distribution;suppleness;	—

Countries

China

Contacts

Public ContactWang Chunmei

Southern Medical University Dermatology Hospital

chunmei22@hotmail.com+86 13717341078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026